Interdisciplinary research
Our research is a transdisciplinary merger of expertise in immunology, nanotechnology, materials science, microbiology, neuroscience, cancer biology, gerontology, clinical science, and social science. We are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, antimicrobial resistance, cancer, aging, and animal health.
Our vision is that nanovaccines and nanotherapeutics will revolutionize how we prevent and treat disease.
Collaboration across the United States
The Nanovaccine Institute is a consortium of researchers located throughout the country. Follow the link below to learn more about their research impacts.
Revolutionizing how we
prevent and treat disease
6
6
Focus Areas
85
85
Researchers
26
26
Institutions